Clinical Trials in Illinois

Showing 1501-1520 of 9,411 trials

Establishment of ProNephro AKI (NGAL) Cut Off Value for Risk Assessment of Moderate to Severe Acute Kidney Injury in Adults

NCT06652100

The purpose of this research is to collect blood and urine from adult patients admitted to an intensive care unit. This is to assess the performance of the ProNephro AKI (NGAL) assay (lab test) as an aid to identify patients at risk for acute kidney injury.

Acute Kidney Injury

BioPorto Diagnostics800 participantsStarted Oct 2024

Birmingham, Alabama, United States • Sacramento, California, United States • New Haven, Connecticut, United States +9 more locations

Active Not RecruitingPhase 2125 miles

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a New Formulation of Cabotegravir Long-Acting Administered Intramuscularly in a 4-month Dosing Interval (Q4M)

NCT06741397

This study will evaluate the pharmacokinetics (PK), safety, and tolerability of a new formulation of Cabotegravir (CAB) dosed every 4-months (Q4M) for pre-exposure prophylaxis (PrEP) in participants at risk of HIV-1 acquisition.

HIV Infections

ViiV Healthcare229 participantsStarted Dec 2024

Birmingham, Alabama, United States • Los Angeles, California, United States • Los Angeles, California, United States +24 more locations

Establishment of ProNephro AKI (NGAL) Cut Off Value for Risk Assessment of Moderate to Severe Acute Kidney Injury in Adults

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a New Formulation of Cabotegravir Long-Acting Administered Intramuscularly in a 4-month Dosing Interval (Q4M)

Find Trials by Condition in Illinois

Study to Assess the Effect of Long-term Treatment With Voxelotor in Participants Who Have Completed Treatment in Study GBT440-031

Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation

A Phase III Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Non Small Cell Lung Cancer (NSCLC) Whose Disease Progressed On or After Prior Anti PD (L)1 Therapy And Platinum Based Chemotherapy

A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement - (FIGHT-203)

The Synergy Disc To Anterior Cervical Discectomy and Fusion

Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants

A Randomized, Double-Blind, Placebo-Controlled Trial of IkT-148009 in Untreated Parkinson's Disease

Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors

UBX-303061 in Subjects With Relapsed/Refractory B-Cell Malignancies

A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or Dermatomyositis

Utilizing CT Based Imaging Parameters of Body Composition to Understand Heterogeneity of Response to Biologic Therapies in Severe Asthma Cohorts

Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR

Natural History Study Protocol in PMM2-CDG (CDG-Ia)

A Phase 1 Study of BHV-1530 in Advanced Solid Tumors

Study of AVZO-021 in Patients With Advanced Solid Tumors

MARGetuximab Or Trastuzumab (MARGOT)

A Phase II Randomized Study Comparing the Efficacy and Safety of Targeted Therapy or Cancer Immunotherapy Versus Platinum-Based Chemotherapy in Patients With Cancer of Unknown Primary Site

Pharmacogenomics for Better Treatment of Fungal Infections in Cancer